|
恒瑞医药(600276)限售解禁 | 解禁日期 | 本期流通股本 (万股) | 本期流通股本占 总股本比例(%) | 已流通股本 (万股) | 未流通股本 (万股) | 流通A股 (万股) | 流通A股占 总股本比例(%) | 限售股类型 | 2021-10-25 | 1148.47 | 0.18% | 637900.23 | 1847.53 | 639747.76 | 100.00% | 股权激励限售流通 | 2021-02-01 | 243.65 | 0.05% | 530626.46 | 2545.24 | 533171.70 | 100.00% | 股权激励限售流通 | 2021-01-21 | 809.02 | 0.15% | 530382.82 | 2788.89 | 533171.70 | 100.00% | 股权激励限售流通 | 2020-02-03 | 217.17 | 0.05% | 441311.49 | 969.93 | 442281.42 | 100.00% | 股权激励限售流通 | 2020-01-20 | 702.82 | 0.16% | 441094.32 | 1187.10 | 442281.42 | 100.00% | 股权激励限售流通 | 2019-01-22 | 798.12 | 0.22% | 366992.92 | 1214.80 | 368207.71 | 100.00% | 股权激励限售流通 | 2018-01-31 | 57.45 | 0.02% | 281688.30 | 1576.50 | 283264.80 | 100.00% | 股权激励限售流通 | 2017-07-25 | 402.41 | 0.14% | 281630.85 | 58.13 | 281688.98 | 100.00% | 股权激励限售流通 | 2017-01-16 | 47.88 | 0.02% | 234357.04 | 388.93 | 234745.97 | 100.00% | 股权激励限售流通 | 2016-07-19 | 348.83 | 0.15% | 234309.16 | 467.13 | 234776.29 | 100.00% | 股权激励限售流通 | 2016-01-21 | 53.20 | 0.03% | 194966.94 | 682.97 | 195649.91 | 100.00% | 股权激励限售流通 | 2015-07-17 | 402.12 | 0.21% | 194913.75 | 736.16 | 195649.91 | 100.00% | 股权激励限售流通 | 2013-07-05 | 247.27 | 0.18% | 136022.12 | 0.00 | 136022.12 | 100.00% | 股权激励限售流通 | 2012-07-05 | 224.79 | 0.18% | 123431.68 | 224.79 | 123656.47 | 100.00% | 股权激励限售流通 | 2011-07-11 | 272.48 | 0.24% | 112006.26 | 408.72 | 112414.97 | 100.00% | 股权激励限售流通 | 2009-06-22 | 19583.85 | 31.55% | 62074.32 | 0.00 | 62074.32 | 100.00% | 股权分置限售流通 | 2008-06-20 | 5437.86 | 10.51% | 35408.73 | 16319.87 | 51728.60 | 100.00% | 股权分置限售流通 | 2007-06-20 | 8751.72 | 20.30% | 24975.72 | 18131.44 | 43107.17 | 100.00% | 股权分置限售流通 |
|